Author name: suadm

New Funding Opportunity: Patient-Centric Clinical Trial Team Science Awards July 19, 2022 The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards …

New Funding Opportunity: Patient-Centric Clinical Trial Team Science Awards Read More »

Lithuania liberalizes labor migration July 14, 2022 We are excited to celebrate liberalization of labor migration of non-EU nationals passed into law in late June by the Lithuanian parliament. This takes place just under a year after the team at Lithuanian Free Market Institute (LFMI) initiated discussions on systemic reform to address looming demographic and labor market …

Lithuania liberalizes labor migration Read More »

Scientists discover genes that affect the risk of developing pre-leukaemia July 14, 2022 The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today in Nature Genetics. The finding, made in …

Scientists discover genes that affect the risk of developing pre-leukaemia Read More »

Going the extra mile for people with pancreatic cancer July 12, 2022 BRUSSELS – The Anticancer Fund is partnering with the Rising Tide Foundation for Clinical Cancer Research to support a trial testing a novel strategy in the treatment of patients with pancreatic cancer. As people with pancreatic cancer are currently lacking treatment options, the …

Going the extra mile for people with pancreatic cancer Read More »

RTFCCR grantee update: Impact of DNA mutations on lifelong blood cell production uncovered July 1, 2022 Researchers discover how leukaemia-associated gene mutations steadily commandeer blood cell production over a lifetime, and how these changes relate to ageing and cancer development. New research by scientists at the Wellcome Sanger Institute, the Cambridge Stem Cell Institute, EMBL’s …

RTFCCR grantee update: Impact of DNA mutations on lifelong blood cell production uncovered Read More »